Cargando…

Screening for head and neck second primary tumors in patients with esophageal squamous cell cancer: A systematic review and meta-analysis

BACKGROUND: Esophageal squamous cell carcinomas (ESCCs) are often accompanied by head and neck second primary tumors (HNSPTs). The prognosis of patients with an additional HNSPT is worse compared with patients with only ESCC. Therefore, early detection of HNSPTs may improve the overall outcome of pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	van de Ven, SEM, Bugter, O, Hardillo, JA, Bruno, MJ, Baatenburg de Jong, RJ, Koch, AD
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893998/ https://www.ncbi.nlm.nih.gov/pubmed/31839955 http://dx.doi.org/10.1177/2050640619856459

Ejemplares similares

Early detection of esophageal second primary tumors using Lugol chromoendoscopy in patients with head and neck cancer: A systematic review and meta‐analysis
por: Bugter, Oisín, et al.
Publicado: (2018)

Screening for synchronous esophageal second primary tumors in patients with head and neck cancer
por: van de Ven, Steffi E M, et al.
Publicado: (2021)

A cause‐specific Cox model for second primary tumors in patients with head and neck cancer: A RONCDOC study
por: Bugter, Oisín, et al.
Publicado: (2021)

Screening for head and neck tumors in patients with esophageal squamous cell carcinoma and vice versa: a nationwide survey among medical specialists
por: van Tilburg, Laurelle, et al.
Publicado: (2022)

Endoscopic screening of the upper gastrointestinal tract for second primary tumors in patients with head and neck cancer in a Western country
por: van Tilburg, Laurelle, et al.
Publicado: (2023)

Survival of patients with head and neck cancer with metachronous multiple primary tumors is surprisingly favorable
por: Bugter, Oisín, et al.
Publicado: (2019)

Surgical management of inverted papilloma; a single-center analysis of 247 patients with long follow-up
por: Bugter, Oisín, et al.
Publicado: (2017)

Head and neck cancer patients’ preferences for individualized prognostic information: a focus group study
por: Hoesseini, Arta, et al.
Publicado: (2020)

Optical detection of field cancerization in the buccal mucosa of patients with esophageal cancer
por: Bugter, Oisín, et al.
Publicado: (2018)

Impact of a prognostic model for overall survival on the decision‐making process in a head and neck cancer multidisciplinary consultation meeting
por: Dorr, Maarten C., et al.
Publicado: (2022)

Propofol sedation without endotracheal intubation is safe for endoscopic submucosal dissection in the esophagus and stomach
por: van de Ven, SEM, et al.
Publicado: (2019)

To screen or not to screen: Reply to “Long-term results of an endoscopic screening program for superficial esophageal cancer in patients with head and neck squamous cell carcinoma”
por: van Tilburg, Laurelle, et al.
Publicado: (2022)

Treatment of head and neck carcinoma of unknown primary: Cracking a nut with a sledgehammer?
por: Berzenji, Diako, et al.
Publicado: (2021)

Increased risk of second primary tumours in patients with oesophageal squamous cell carcinoma: a nationwide study in a Western population
por: van de Ven, Steffi E. M., et al.
Publicado: (2021)

Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands
por: van der Linden, Naomi, et al.
Publicado: (2015)

Long-term results of an endoscopic screening program for superficial esophageal cancer in patients with head and neck squamous cell carcinoma
por: Nobre Moura, Renata, et al.
Publicado: (2022)

Illness cognitions in head and neck squamous cell carcinoma: predicting quality of life outcome
por: Scharloo, Margreet, et al.
Publicado: (2009)

Chromoendoscopy to Detect Early Synchronous Second Primary Esophageal Carcinoma in Patients with Squamous Cell Carcinomas of the Head and Neck?
por: Komínek, Pavel, et al.
Publicado: (2013)

The Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: on Subsets and Subsites
por: Wondergem, Niels E., et al.
Publicado: (2020)

Characteristics of esophageal cancer in patients with head and neck squamous cell carcinoma
por: Wang, Lei, et al.
Publicado: (2021)

Gene-expression of metastasized versus non-metastasized primary head and neck squamous cell carcinomas: A pathway-based analysis
por: Hensen, Erik F, et al.
Publicado: (2008)

Risk Factors for Esophageal Squamous Cell Carcinoma in Patients with Head and Neck Squamous Cell Carcinoma
por: Wang, Lei, et al.
Publicado: (2022)

Endoscopic surveillance of head and neck cancer in patients with esophageal squamous cell carcinoma
por: Kato, Minoru, et al.
Publicado: (2016)

The effect of second hand smoke in patients with squamous cell carcinoma of the head and neck
por: Idris, Sherif, et al.
Publicado: (2019)

Influence of Tea Consumption on the Development of Second Esophageal Neoplasm in Patients with Head and Neck Cancer
por: Wang, Yao-Kuang, et al.
Publicado: (2019)

Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma
por: Morimoto, Hiroyuki, et al.
Publicado: (2017)

Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma
por: Chen, Jin‐Hua, et al.
Publicado: (2016)

Physicians’ clinical prediction of survival in head and neck cancer patients in the palliative phase
por: Hoesseini, Arta, et al.
Publicado: (2020)

Raman spectroscopy to discriminate laryngeal squamous cell carcinoma from non-cancerous surrounding tissue
por: van Lanschot, Cornelia, et al.
Publicado: (2023)

Synchronous Head and Neck Cancer and Superficial Esophageal Squamous Cell Neoplasm: Endoscopic Treatment or No Treatment for the Superficial Esophageal Neoplasm
por: Liu, Chung-Wei, et al.
Publicado: (2023)

Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial(†)
por: Clement, P. M., et al.
Publicado: (2016)

Endoscopic Surveillance for Metachronous Esophageal Squamous Cell Neoplasms among Head and Neck Cancer Patients
por: Chen, Yi-Hsun, et al.
Publicado: (2020)

Ex Vivo Functional Assay for Evaluating Treatment Response in Tumor Tissue of Head and Neck Squamous Cell Carcinoma
por: Capala, Marta E., et al.
Publicado: (2023)

Noncompliance to guidelines in head and neck cancer treatment; associated factors for both patient and physician
por: Dronkers, Emilie A. C., et al.
Publicado: (2015)

The Multidimensional Prognostic Index as a Measure of Frailty in Elderly Patients with Head and Neck Cancer
por: Bakas, Ajay T, et al.
Publicado: (2021)

At the Crossroads of Molecular Biology and Immunology: Molecular Pathways for Immunological Targeting of Head and Neck Squamous Cell Carcinoma
por: Wondergem, Niels E., et al.
Publicado: (2021)

Endoscopic Screening for Second Primary Tumors of the Esophagus Among Head and Neck Cancer Patients
por: Chung, Chen-Shuan, et al.
Publicado: (2022)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Developing an immunotherapy strategy for the effective treatment of patients with squamous cell carcinoma of the head and neck
por: Moudgil, Tarsem, et al.
Publicado: (2013)

Effect of hypoxia on the expression of αB-crystallin in head and neck squamous cell carcinoma
por: van de Schootbrugge, Chantal, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_aolghl0k2bgj0s33u68t7ofpds